samedan logo

 
 
spacer
home > ict > autumn 2018 > modifying methods
PUBLICATIONS
International Clinical Trials

Modifying Methods

ICT: Why has there recently been more interest in adaptive trials?

Dr Sy Pretorius: The UK government announcing a £40 million investment in the Dame Tessa Jowell Brain Cancer Research Mission – which includes speeding up the use of adaptive trials to test different treatments at the same time and streamlining the process – has shed a new spotlight of media interest on the topic, but several reasons exist for this for broader increased interest as well.

For one, regulatory agencies – especially the FDA in the US and EMA in Europe – are encouraging the use of adaptive trials. Both of these agencies have been supportive in terms of their comments around the use of the adaptive designs where appropriate. Additionally, several recent statistical and technological advancements have made these trials more viable.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sy Pretorius MD leads Medical and Scientific Services at PAREXEL. In this role, Sy collaborates with biopharmaceutical and medical device clients in designing and optimising drug/device development strategies and plans, as well as finding, evaluating, and purchasing assets. He is passionate about drug development, leading several initiatives on clinical trial innovation. Sy is a medical doctor with Master's degrees in clinical pharmacology, business administration, and the management of drug development.
spacer
Dr Sy Pretorius
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

EXTERNAL COMMUNICATION, 24 October 2019, Copenhagen, Denmark PRESS RELEASE – FLYPHARMA CONFERENCE EUROPE 2019

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices, putting together a global audience of (bio)pharma and logistics professionals. The two-day conference (22-23 October 2019) aimed to discuss the collaboration and growth within Scandinavia, with a special focus on women in pharmaceutical logistics and an exploration of the industry’s digitalisation and innovation.
More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 
Industry Events

Clinical Trial Supply New England

24-25 March 2020, Boston, US

Following on from another successful conference Arena International will be returning with full force to Waltham in March to celebrate another edition of the Clinical Trial Supply show. 2020 will gather the key stakeholders in the clinical trials community, including the FDA, US Customs and Border Protection, Biogen, Sanofi, and Blueprint Medicines Corporation. With interactive session formats, fresh content and networking, the event will provide attendees with an unparalleled opportunity for collaboration between players across the whole industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement